Primers, probes and methods for screening leukemia mll-sept6 fusion gene by real-time fluorescent PCR
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 北京艾迪康医学检验实验室有限公司
- Publication Date
- 2021-02-23
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology detection, and particularly relates to a method for screening fusion genes, which uses probe Taqman real-time fluorescent PCR technology to detect the situation of MLL-SEPT6 fusion genes in human leukemia patients. Background technique
[0002] Leukemia is a kind of clonal malignant disease with abnormal hematopoietic stem cells. The leukemia cells in its clones lose the ability to further differentiate and mature and stagnate at different stages of cell development. In the bone marrow and other hematopoietic tissues, a large number of leukemia cells proliferate and accumulate and infiltrate other organs and tissues, and at the same time inhibit normal hematopoiesis. The clinical manifestations are anemia, bleeding, infection and infiltration of various organs. The etiology and pathogenesis of human leukemia are still not fully understood. The known causes include infectious factors, ionizing radiat...